Canada Food & Drug Retailing

PharmaCorp Rx Inc (PCRX)

Track

Over the past 90 days, PharmaCorp Rx Inc. recorded six insider transactions, all of which were buys totaling approximately 388,800 CAD. Five distinct insiders, including one executive, participated in these purchases. This activity follows the company's June 2026 results financiers and occurs amid a 5.7% decline in the stock price over the last quarter.
Ticker: PCRX Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for PharmaCorp Rx Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 14 Jul 2026
Value CA$2,334,072.40 | Price 406.91 | Shares 82,475 (+49.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-14 B Purchase
2.6
Simpson, Alan Arthur

Director of Issuer

Non-Executive Director
82,475 +49.4%
406.91
CA$2,334,072 		82,475 +49.4% 406.91 CA$2,334,072
2026-07-15 2026-07-14 B Purchase
2.1
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
45,004 -6.7%
441.02
CA$3,864,678 		45,004 -6.7% 441.02 CA$3,864,678
2026-07-15 2026-07-14 B Purchase
2.1
Dale, Paul Richard

Senior Officer of Issuer

Officer
50,249 -34.5%
104.80
CA$483,116 		50,249 -34.5% 104.80 CA$483,116
2026-07-15 2026-07-14 B Purchase
2.1
Brown, Grady Douglas

Director of Issuer

Non-Executive Director
172,942 +19.1%
0.51
CA$88,200 		172,942 +19.1% 0.51 CA$88,200
2026-07-15 2026-07-09 B Purchase
2.1
Dumont, James

Director of Issuer

Non-Executive Director
34,706 +11.2%
0.51
CA$17,700 		34,706 +11.2% 0.51 CA$17,700
2026-07-15 2026-07-09 B Purchase
2.1
Dumont, James

Director of Issuer

Non-Executive Director
34,706 +9.4%
0.51
CA$17,700 		34,706 +9.4% 0.51 CA$17,700
2025-11-14 2025-11-12 B Purchase
2.6
Simpson, Alan Arthur

Director of Issuer

Non-Executive Director
2,380,960 +95.2%
0.42
CA$1,000,003 		2,380,960 +95.2% 0.42 CA$1,000,003
2025-11-14 2025-11-12 B Purchase
2.1
Dumont, James

Director of Issuer

Non-Executive Director
59,524
0.42
CA$25,000 		59,524 0.42 CA$25,000
2025-11-14 2025-11-12 B Purchase
2.1
Dumont, James

Director of Issuer

Non-Executive Director
178,650 +71.5%
0.42
CA$75,033 		178,650 +71.5% 0.42 CA$75,033
2025-11-13 2025-11-12 B Purchase
2.1
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
59,500 +11.9%
0.42
CA$24,990 		59,500 +11.9% 0.42 CA$24,990
2025-11-13 2025-11-12 B Purchase
2.1
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
71,510
0.42
CA$30,034 		71,510 0.42 CA$30,034
2025-11-13 2025-11-12 B Purchase
2.1
Dale, Paul Richard

Senior Officer of Issuer

Officer
238,100
0.42
CA$100,002 		238,100 0.42 CA$100,002
2025-11-13 2025-11-12 B Purchase
2.1
Brownell, Kenneth Alva

Director of Issuer

Non-Executive Director
238,000 +64.0%
0.42
CA$99,960 		238,000 +64.0% 0.42 CA$99,960
2025-11-13 2025-11-12 B Purchase
2.1
Brown, Grady Douglas

Director of Issuer

Non-Executive Director
595,240 +190.5%
0.42
CA$250,001 		595,240 +190.5% 0.42 CA$250,001
Explore more

More insider trading research around PharmaCorp Rx Inc

More insider trades in Canada
Similar Consumer Non-Cyclicals companies with insider activity
More Food & Drug Retailing companies with insider activity
More Food & Drug Retailing companies with insider activity
Insider trading in North America